(Q80188458)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

TCP isoeffect analysis using a heterogeneous distribution of radiosensitivity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Marco Carlone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

David Wilkins

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Balazs Nyiri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Peter Raaphorst

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 May 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1176-1182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

Comparison of alpha/beta estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer

29 December 2019

cites work

1 reference

Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data

21 January 2018

1 reference

Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression

21 January 2018

1 reference

Optimum parameters in a model for tumour control probability including interpatient heterogeneity

21 January 2018

1 reference

The linear-quadratic formula and progress in fractionated radiotherapy

21 January 2018

1 reference

A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low

21 January 2018

1 reference

Incorporating biologic measurements (SF2, CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy

21 January 2018

1 reference

Should single or distributed parameters be used to explain the steepness of tumour control probability curves?

21 January 2018

1 reference

Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.

21 January 2018

1 reference

A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity

21 January 2018

1 reference

Toward optimal external-beam fractionation for prostate cancer

21 January 2018

1 reference

Fractionation and protraction for radiotherapy of prostate carcinoma

21 January 2018

1 reference

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

21 January 2018

1 reference

Is the alpha/beta ratio for prostate cancer low?

21 January 2018

1 reference

Is the alpha/beta for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021-1031.

21 January 2018

1 reference

Is alpha/beta for prostate tumors really low?

21 January 2018

1 reference

What hypofractionated protocols should be tested for prostate cancer?

21 January 2018

1 reference

The prospects for new treatments for prostate cancer

21 January 2018

1 reference

Yes, the alpha/beta ratio for prostate cancer is low or "methinks the lady doth protest too much...about a low alpha/beta that is"

21 January 2018

1 reference

In regard to Brenner et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio) similar to late-responding normal tissue.

21 January 2018

1 reference

Hypofractionation for prostate cancer

21 January 2018

1 reference

How low is the α/β ratio for prostate cancer?

21 January 2018

1 reference

How low is the alpha/beta ratio for prostate cancer?

21 January 2018

1 reference

The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us?

21 January 2018

1 reference

The influence of brachytherapy dose heterogeneity on estimates of / for prostate cancer

21 January 2018

1 reference

Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1118/1.1711415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15191307%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference